| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | OPTT | United States | $0.25 | $5,861,000.00 | Strong Buy | 2 | 2006 |
#2 | BLNK | United States | $0.61 | $126,197,000.00 | Buy | 4 | 2008 |
#3 | RANI | United States | $0.74 | $1,633,000.00 | Strong Buy | 4 | 2021 |
#4 | PROP | United States | $0.66 | $7,939,000.00 | Buy | 5 | 2008 |
#5 | MVIS | United States | $0.29 | $664,000.00 | Strong Buy | 3 | 2010 |
#6 | HOWL | United States | $0.32 | $0.00 | Strong Buy | 4 | 2021 |
#7 | CNTX | United States | $0.59 | $0.00 | Strong Buy | 6 | 2021 |
#8 | ATNM | United States | $0.99 | $90,000.00 | Strong Buy | 2 | 2013 |
#9 | SACH | United States | $0.95 | $0.00 | Buy | 2 | N/A |
#10 | QSI | United States | $0.85 | $0.00 | Buy | 2 | N/A |
#11 | BEAT | United States | $0.68 | $0.00 | Strong Buy | 4 | N/A |
#12 | MDXH | Belgium | $0.43 | $0.00 | Strong Buy | 3 | 2021 |
#13 | CAN | Singapore | $0.31 | $0.00 | Strong Buy | 6 | 2019 |
#14 | LGO | Canada | $0.64 | $0.00 | Strong Buy | 2 | 2007 |
#15 | JSPR | United States | $0.34 | $0.00 | Buy | 11 | N/A |
#16 | ELBM | Canada | $0.52 | $0.00 | Strong Buy | 2 | 2022 |
#17 | BIOX | Argentina | $0.33 | $0.00 | Buy | 3 | 2019 |
#18 | ARBE | Israel | $0.66 | $0.00 | Strong Buy | 2 | N/A |
#19 | ENLV | Israel | $0.57 | $0.00 | Buy | 2 | 2014 |
#20 | VRME | United States | $0.60 | $0.00 | Strong Buy | 2 | N/A |
#21 | HRTX | United States | $0.43 | $154,904,000.00 | Strong Buy | 2 | 2007 |
#22 | WWR | United States | $0.48 | $0.00 | Strong Buy | 3 | 2006 |
#23 | PHIO | United States | $0.97 | $0.00 | Strong Buy | 2 | 2011 |
#24 | NFE | United States | $0.35 | $1,504,037,000.00 | Buy | 3 | 2018 |
#25 | DCGO | United States | $0.49 | $322,196,000.00 | Strong Buy | 4 | 2020 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $1 to Buy (June 27, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.